Dexmedetomidine in Patients After Intracranial Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

February 28, 2013

Conditions
Central Nervous System Diseases
Interventions
DRUG

Dexmedetomidine

Intravenous infusion at rate of 0.4μg/kg/h, during the first 24 hours postoperatively

DRUG

Normal saline

as placebo

Trial Locations (1)

100050

Neuro-ICU, Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER

NCT01445639 - Dexmedetomidine in Patients After Intracranial Surgery | Biotech Hunter | Biotech Hunter